Yoshida Koji, Forrest Shelley L, Ichimata Shojiro, Tanaka Hidetomo, Kon Tomoya, Kovacs Gabor G
Department of Laboratory Medicine and Pathobiology and Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
Tanz Centre for Research in Neurodegenerative Disease, Krembil Discovery Tower, University of Toronto, Toronto, Ontario, Canada.
Alzheimers Dement. 2025 Jan;21(1):e14355. doi: 10.1002/alz.14355. Epub 2024 Dec 23.
Limited research has extensively analyzed neurodegenerative disease-related protein deposition patterns in the hippocampus.
This study examined the distribution of proteins in hippocampal subregions across major neurodegenerative diseases and explored their relation to each other. The area density of phosphorylated tau (p-tau), amyloid beta (Aβ), α-synuclein, and phosphorylated TDP-43 protein deposits together with pyramidal cell density in each hippocampal subregion, including CA1-4, prosubiculum (ProS), and subiculum was assessed in 166 cases encompassing various neurodegenerative diseases.
Alzheimer's disease-associated p-tau predominated in ProS, Aβ in the CA1, and Lewy body-related α-synuclein in the CA2. The area density of protein deposits increased with the pathological stage until a peak, then decreased in cases with high pathology stages along with pyramidal cell density. Comorbid protein pathology influenced protein deposition patterns.
This comprehensive evaluation reveals characteristic neurodegenerative disease-related protein accumulation patterns in hippocampal subregions modified by co-pathologies.
Alzheimer's disease-related phosphorylated tau predominates in the prosubiculum. Amyloid beta predominates in the CA1 and Lewy body-related α-synuclein in the CA2. The area density of protein deposition increases with the disease stage up to a peak. In the high pathology stage, protein deposition and pyramidal cell density decreases. Comorbid protein pathology affects the pattern of protein accumulation.
有限的研究广泛分析了海马体中与神经退行性疾病相关的蛋白质沉积模式。
本研究检查了主要神经退行性疾病中海马体亚区域蛋白质的分布情况,并探讨了它们之间的相互关系。在166例涵盖各种神经退行性疾病的病例中,评估了每个海马体亚区域(包括CA1 - 4、前下托(ProS)和下托)中磷酸化tau(p - tau)、淀粉样β蛋白(Aβ)、α - 突触核蛋白和磷酸化TDP - 43蛋白沉积物的面积密度以及锥体细胞密度。
与阿尔茨海默病相关的p - tau在前下托中占主导,Aβ在CA1中占主导,与路易体相关的α - 突触核蛋白在CA2中占主导。蛋白质沉积物的面积密度随着病理阶段的增加而增加,直至达到峰值,然后在高病理阶段的病例中随着锥体细胞密度的下降而下降。合并的蛋白质病理影响蛋白质沉积模式。
这项综合评估揭示了海马体亚区域中与神经退行性疾病相关的特征性蛋白质积累模式,这些模式会因合并病理而改变。
与阿尔茨海默病相关的磷酸化tau在前下托中占主导。淀粉样β蛋白在CA1中占主导,与路易体相关的α - 突触核蛋白在CA2中占主导。蛋白质沉积的面积密度随着疾病阶段的增加而增加,直至达到峰值。在高病理阶段,蛋白质沉积和锥体细胞密度下降。合并的蛋白质病理影响蛋白质积累模式。